In this guide (7 sections)
When an insurance company denies an addiction-treatment claim, the language it almost always uses is some version of: "This service is not medically necessary at this level of care." The phrase sounds like a clinical judgment. In practice it is something narrower and more contested — an application of a specific criteria document to a specific patient's record, by a specific utilization-review clinician, under specific contract terms. Understanding the phrase is the first step in challenging it productively.
This guide unpacks what "medical necessity" actually means in the insurance context, what changed under the 2024 federal parity rule, and how a patient or family can use the rule to get a better answer than the first denial provides.
The four prongs of medical necessity
Almost every insurer's definition of medical necessity includes four elements. A service is medically necessary if it is: (1) consistent with generally accepted standards of care; (2) clinically appropriate for the patient's condition and documented situation; (3) not more intensive than the clinical picture requires; (4) not provided primarily for patient convenience. Each of these prongs is independently audible. Each is independently challengeable on appeal.
What gets contested is rarely the general definition. What gets contested is the operational translation — the specific document that tells a utilization-review clinician which thresholds count as "appropriate" and which count as "more intensive than required." For addiction treatment, these documents have been historically opaque and, in several documented cases (including the Wit v. UBH federal ruling in 2020), calibrated toward cost-reduction rather than clinical appropriateness.
What the 2024 parity rule changed
Under the Mental Health Parity and Addiction Equity Act (MHPAEA) final rule published in September 2024, insurers must now produce a written comparative analysis showing that non-quantitative treatment limits — including medical-necessity criteria — are applied no more stringently for behavioral-health care than for medical-surgical care. The rule requires plans to disclose the specific medical-necessity criteria applied to any given claim, within 10 business days of a request from a plan participant.
Operationally, this means a patient who receives a denial now has a concrete right: the right to see, in writing, the exact criteria applied and the comparative-analysis document demonstrating parity compliance. Refusal to produce these documents is itself a parity violation, independent of the underlying denial.
The rule is being enforced unevenly — by the Department of Labor for employer-sponsored plans, by state insurance commissioners for individual and small-group plans. Early enforcement patterns in 2025-2026 suggest appeal-reversal rates have increased meaningfully when patients cite specific criteria rather than arguing clinical judgment in general terms.
How to read a medical-necessity criteria document
When you obtain a plan's medical-necessity criteria for your denied claim, read for three things:
1. What clinical source does the document cite? If the document references ASAM Criteria (4th edition, 2023), SAMHSA Treatment Improvement Protocols, or DSM-5-TR — those are consensus external standards. The document is aligned with generally accepted clinical standards. If the document references MCG Health, InterQual, or an internal-only framework without external citation, the criteria are proprietary and substantially more challengeable.
2. What specific thresholds do they apply? Criteria typically specify quantifiable thresholds — "must have demonstrated failure at a lower level of care within the past 12 months," "must have documented risk of dangerous withdrawal," "must show evidence of X, Y, or Z clinical indicator." Compare each threshold against your clinical documentation. Gaps between the threshold and your record are the substantive basis of a successful appeal.
3. What appeal standards do they describe? Criteria documents usually describe what additional documentation would change the determination. A thorough ASAM 4e-aligned assessment from an independent treating clinician is frequently dispositive. A peer-review call between your treating clinician and the plan's medical director is often offered as an appeal step. Failure of prior outpatient care is often documentable through therapist or physician notes.
How to frame an appeal that works
The single most important operational move in an effective appeal is to cite the criteria document directly. Instead of arguing that the denial is clinically wrong in general terms, argue that the denial is inconsistent with the plan's own criteria as applied to the clinical documentation. This framing is harder for the plan's utilization-review team to dismiss.
A productive appeal letter typically follows a structure:
- Identify the specific criteria document applied. "Per the medical-necessity criteria for residential substance-use treatment dated [date], the plan requires [threshold]."
- Point to the clinical documentation that meets the threshold. "The attached ASAM 4e assessment from [clinician] dated [date] documents [specific clinical finding] that satisfies this threshold."
- Note any discrepancy between the denial rationale and the criteria. "The denial letter cites [reason]. This reason does not appear in the medical-necessity criteria, or is inconsistent with the threshold the criteria specify."
- Request specific relief. "Based on the foregoing, the claim should be approved at [specific level of care] for [specific day count]."
Most accredited treatment centers that accept commercial insurance have utilization-review staff who draft this type of appeal on the patient's behalf. Ask explicitly whether your facility provides this service. If the answer is "no, the patient files appeals," that itself is useful information about how seriously the facility treats the back-end benefits work.
What to do if the first appeal is denied
The appeal pathway is layered. Most plans offer:
- First-level internal appeal — typically 30-60 days for standard review, 72 hours for expedited review when treatment is in progress.
- Second-level internal appeal — often 30 days after first-level adjudication.
- External review — through an Independent Review Organization (IRO) or the state insurance commissioner, typically decided within 45 days after internal appeals are exhausted. IRO decisions are binding on the plan.
- Parity-specific enforcement — through the Department of Labor (for employer-sponsored plans under ERISA) or state insurance regulator, focused specifically on whether the plan's non-quantitative treatment limits comply with MHPAEA.
- Federal litigation — for ERISA plans, under 29 U.S.C. § 1132, when internal and external review have not produced relief.
Most reversals happen at second-level internal review or external IRO review, not first-level. The work of preparing the substantive record — clinical documentation, criteria analysis, appeal letter — is what makes those later reviews productive.
What has not changed
The 2024 parity rule did not guarantee that insurers will cover any specific treatment any specific patient wants. It required only that the mechanism for making coverage decisions be no more burdensome for behavioral-health care than for medical-surgical care. Coverage for residential addiction treatment still has to be medically necessary by the plan's criteria; what changed is that the criteria are now auditable and the audit is mandatory.
Enforcement is also still evolving. Some states (California under SB 855, for example) have stronger parity enforcement than others. Some employer plans face more scrutiny than individual or small-group plans. The specific experience of appealing a denial in 2026 depends meaningfully on jurisdiction, plan type, and the specific insurer.
What is consistent is that the playing field has shifted. A patient facing a denial in 2026 has materially more leverage than the same patient would have had in 2022 — if the patient knows what to ask for, how to read the criteria, and how to frame the appeal. This guide is an orientation to those three things.
Sources
- DOL/HHS/Treasury. Mental Health Parity and Addiction Equity Act Final Rule, September 2024. dol.gov
- Wit v. United Behavioral Health. Case No. 14-cv-02346 (N.D. Cal., March 5, 2020 ruling).
- American Society of Addiction Medicine. The ASAM Criteria, 4th edition (2023). asam.org
- SAMHSA. Treatment Improvement Protocols (TIPs) — referenced in most major payer medical-necessity documents.
- CMS. Mental Health Parity compliance database and enforcement actions.
Sources & References
The specific citations for this guide appear inline above. For our general sourcing framework across all articles:
- SAMHSA — Treatment Improvement Protocols (TIPs)
- NIDA — Principles of Drug Addiction Treatment
- ASAM — The ASAM Criteria (4th ed.)
- CDC — Drug Overdose Surveillance
- CMS — Mental Health Parity and Addiction Equity Act
See our editorial policy for how we source and fact-check.
Published by Pine Valley Recovery
Understand your treatment options. Plan what it will actually cost. Then decide. Read our editorial policy →